Roche says development drug helps in breast cancer
Home page > News

Roche says development drug helps in breast cancer

www.reuters.com   | 30.03.2012.

ZURICH (Reuters) - Roche said patients with an aggressive type of breast cancer lived longer after taking an experimental "armed antibody" drug without the disease worsening than patients taking a combination of GlaxoSmithKline drug Tykerb and Roche's Xeloda.
br />

Though Roche said the Phase III data are not yet mature, the safety of the development drug -- dubbed T-DM1 -- is consistent with previous studies.

Roche said it plans to submit the treatment to European and U.S. authorities for approval this year.

(Reporting By Katharina Bart)


Comments (0) Add Your comment Add news < Previous news Next news >






  Add your news >>>